Literature DB >> 21114623

Functional expression and characterization of CYP51 from dandruff-causing Malassezia globosa.

Donghak Kim1, Young-Ran Lim, Seul Ong Ohk, Beom Joon Kim, Young-Jin Chun.   

Abstract

Malassezia globosa is one of the most common yeasts to cause various human skin diseases including dandruff and seborrheic dermatitis. Genomic analysis of M. globosa revealed four putative cytochrome P450 (CYP) enzymes. Here, we report the purification and characterization of recombinant CYP51, a putative lanosterol 14α-demethylase, from M. globosa. The M. globosa CYP51 was expressed heterologously in Escherichia coli, followed by purification. Purified CYP51 showed a typical reduced CO-difference spectrum of P450, with a maximum absorption at 447 nm. Purified CYP51 exhibited tight binding to azole antifungal agents such as ketoconazole, econazole, fluconazole, or itraconazole, with K(d) values around 0.26-0.84 μM, which suggests that CYP51 is an orthologous target for antifungal agents in the M. globosa. In addition, three mutations (Y127F, A169S, and K176N) in the amino acid sequence of M. globosa CYP51 were identified in one of the azole-resistant strains. Homology modeling of M. globosa CYP51 suggested that the Y127F mutation may influence the resistance to azoles by blocking substrate access channels. Taken together, functional expression and characterization of the CYP51 enzyme can provide a fundamental basis for a specific antifungal drug design for dandruff caused by M. globosa.
© 2010 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21114623     DOI: 10.1111/j.1567-1364.2010.00692.x

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  9 in total

1.  The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.

Authors:  Andrew G S Warrilow; Josie E Parker; Claire L Price; Edward P Garvey; William J Hoekstra; Robert J Schotzinger; Nathan P Wiederhold; W David Nes; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 2.  The Malassezia genus in skin and systemic diseases.

Authors:  Georgios Gaitanis; Prokopios Magiatis; Markus Hantschke; Ioannis D Bassukas; Aristea Velegraki
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 3.  Resistance to antifungals that target CYP51.

Authors:  Josie E Parker; Andrew G S Warrilow; Claire L Price; Jonathan G L Mullins; Diane E Kelly; Steven L Kelly
Journal:  J Chem Biol       Date:  2014-08-27

4.  Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods.

Authors:  Tomasz Jagielski; Elżbieta Rup; Aleksandra Ziółkowska; Katarzyna Roeske; Anna B Macura; Jacek Bielecki
Journal:  BMC Dermatol       Date:  2014-03-07

5.  Analysis of the ergosterol biosynthesis pathway cloning, molecular characterization and phylogeny of lanosterol 14 α-demethylase (ERG11) gene of Moniliophthora perniciosa.

Authors:  Geruza de Oliveira Ceita; Laurival Antônio Vilas-Boas; Marcelo Santos Castilho; Marcelo Falsarella Carazzolle; Carlos Priminho Pirovani; Alessandra Selbach-Schnadelbach; Karina Peres Gramacho; Pablo Ivan Pereira Ramos; Luciana Veiga Barbosa; Gonçalo Amarante Guimarães Pereira; Aristóteles Góes-Neto
Journal:  Genet Mol Biol       Date:  2014-11-03       Impact factor: 1.771

Review 6.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

7.  Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.

Authors:  Andrew G S Warrilow; Claire L Price; Josie E Parker; Nicola J Rolley; Christopher J Smyrniotis; David D Hughes; Vera Thoss; W David Nes; Diane E Kelly; Theodore R Holman; Steven L Kelly
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

8.  Widespread Occurrence of a CYP51A Pseudogene in Calonectria pseudonaviculata.

Authors:  Stefanos Stravoravdis; Nicholas R LeBlanc; Robert E Marra; Jo Anne Crouch; Jonathan P Hulvey
Journal:  Mycobiology       Date:  2019-11-23       Impact factor: 1.858

9.  Azole resistance mechanisms in pathogenic M. furfur.

Authors:  Cheryl Leong; Joel Chan Wai Kit; Shi Mun Lee; Yuen In Lam; Joleen P Z Goh; Giuseppe Ianiri; Thomas L Dawson
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.